Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.

Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP.

Vaccine. 2010 Mar 11;28(12):2442-9. doi: 10.1016/j.vaccine.2009.12.079. Epub 2010 Jan 12.

PMID:
20074687
2.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
4.

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

Rimmelzwaan GF, Sutter G.

Expert Rev Vaccines. 2009 Apr;8(4):447-54. doi: 10.1586/erv.09.4. Review.

PMID:
19348560
5.

A pandemic influenza vaccine in India: from strain to sale within 12 months.

Dhere R, Yeolekar L, Kulkarni P, Menon R, Vaidya V, Ganguly M, Tyagi P, Barde P, Jadhav S.

Vaccine. 2011 Jul 1;29 Suppl 1:A16-21. doi: 10.1016/j.vaccine.2011.04.119. Review.

6.

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

Rudenko L, van den Bosch H, Kiseleva I, Mironov A, Naikhin A, Larionova N, Bushmenkov D.

Vaccine. 2011 Jul 1;29 Suppl 1:A40-4. doi: 10.1016/j.vaccine.2011.04.122. Review.

7.

Critical review of current and emerging quantification methods for the development of influenza vaccine candidates.

Manceur AP, Kamen AA.

Vaccine. 2015 Nov 4;33(44):5913-9. doi: 10.1016/j.vaccine.2015.07.104. Epub 2015 Aug 10. Review.

PMID:
26271833
8.

[Development of influenza vaccines against newly emerging A/H5N1 virus].

Itamura S.

Nihon Rinsho. 2000 Jan;58(1):255-64. Review. Japanese.

PMID:
10885322
9.

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

D'Aoust MA, Couture MM, Charland N, Trépanier S, Landry N, Ors F, Vézina LP.

Plant Biotechnol J. 2010 Jun;8(5):607-19. doi: 10.1111/j.1467-7652.2009.00496.x. Epub 2010 Feb 18. Review.

10.

A fast track influenza virus vaccine produced in insect cells.

Cox MM, Hashimoto Y.

J Invertebr Pathol. 2011 Jul;107 Suppl:S31-41. doi: 10.1016/j.jip.2011.05.003. Review.

PMID:
21784229
11.

The new H1N1 and HPV vaccines and old fears.

Balofsky A, Agmon-Levin N, Shoenfeld Y.

Curr Opin Rheumatol. 2010 Jul;22(4):431-6. doi: 10.1097/BOR.0b013e32833a43c3. Review.

PMID:
20485175
12.

Development and strategies of cell-culture technology for influenza vaccine.

Feng SZ, Jiao PR, Qi WB, Fan HY, Liao M.

Appl Microbiol Biotechnol. 2011 Feb;89(4):893-902. doi: 10.1007/s00253-010-2973-9. Epub 2010 Nov 10. Review.

PMID:
21063703
13.

Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.

Thompson CM, Petiot E, Lennaertz A, Henry O, Kamen AA.

Virol J. 2013 May 4;10:141. doi: 10.1186/1743-422X-10-141. Review.

14.

Revision of QSAR, docking, and molecular modeling studies of anti-influenza virus A (H1N1) drugs and targets: analysis of hemagglutinins 3D structure.

Dave K, Gandhi M, Panchal H, Vaidya M.

Curr Comput Aided Drug Des. 2011 Dec;7(4):255-62. Review.

PMID:
22050681
15.

[Inactivated influenza virus vaccine: the status quo and several new approaches for future application].

Yamane N.

Nihon Rinsho. 1997 Oct;55(10):2732-7. Review. Japanese.

PMID:
9360399
16.

Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond.

Yusibov V, Streatfield SJ, Kushnir N.

Hum Vaccin. 2011 Mar;7(3):313-21. Epub 2011 Mar 1. Review.

PMID:
21346417
17.

New tests for an old foe: an update on influenza screening.

Wittman V, Byers A, Drake D, Kachurina O, Tapia T, Warren W, Kachurin A.

IDrugs. 2010 Apr;13(4):248-53. Review.

PMID:
20373254
18.

A launch vector for the production of vaccine antigens in plants.

Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G, Brodelius M, Brodelius P, Horsey A, Ugulava N, Shamloul AM, Mett V, Rabindran S, Streatfield SJ, Yusibov V.

Influenza Other Respir Viruses. 2007 Jan;1(1):19-25. doi: 10.1111/j.1750-2659.2006.00005.x. Review.

19.

Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications.

Sparrow E, Friede M, Sheikh M, Torvaldsen S, Newall AT.

Vaccine. 2016 Oct 26;34(45):5442-5448. doi: 10.1016/j.vaccine.2016.08.057. Epub 2016 Sep 9. Review.

20.

New technologies for new influenza vaccines.

Shaw A.

Vaccine. 2012 Jul 13;30(33):4927-33. doi: 10.1016/j.vaccine.2012.04.095. Epub 2012 May 9. Review.

PMID:
22579861

Supplemental Content

Support Center